The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of high patient out-of-pocket (OOP) cost for oral tyrosine kinase inhibitors (TKIs) on survival in EGFR and ALK positive stage IV non-small cell lung cancer (NSCLC).
 
Bernardo H. L. Goulart
Travel, Accommodations, Expenses - Flatiron Health
 
Joseph M. Unger
No Relationships to Disclose
 
Shasank Chennupati
No Relationships to Disclose
 
Kathryn Egan
No Relationships to Disclose
 
Catherine R. Fedorenko
No Relationships to Disclose
 
Scott David Ramsey
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Cascadian Therapeutics; Epigenomics; Genentech; Kite, a Gilead company; Merck; Seagen
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Microsoft (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Bristol-Myers Squibb; Flatiron Health